LONG-TERM RESULTS AND PROGNOSTIC ANALYSES IN RECURRENT/REFRACTORY EPITHELIAL OVARIAN CANCER (RREOC) TREATED BY HIGH-DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS STEM CELL SUPPORT (ASCS)
LONG-TERM RESULTS AND PROGNOSTIC ANALYSES IN RECURRENT/REFRACTORY EPITHELIAL OVARIAN CANCER (RREOC) TREATED BY HIGH-DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS STEM CELL SUPPORT (ASCS)